BeOne Medicines
Oleg Zernovak, M.D., is a seasoned medical professional with extensive experience in hematology and clinical development. Currently serving as Executive Director of Hematology at BeiGene, Oleg has held various leadership roles including Consultant, Vice President of Clinical Development at Curis, and Senior Medical Director at Cellectis. Oleg's prior experience includes serving as Senior Director of Clinical Development at Janssen Inc. Oleg Zernovak earned a Doctor of Medicine (M.D.) degree in Pediatrics from Azerbaijan Medical University.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.